Sign Out
There are no studies for gliquidone in pregnant or lactating women.
Gliquidone was not teratogenic in animal studies. However, embryotoxic effects were observed in rabbits at high doses leading to permanent hypoglycaemia (see Pharmacology: Toxicology under Actions).
It is not known, whether gliquidone or its metabolites are excreted in human milk.
In pregnant diabetics, a particularly close and intensive control of plasma glucose concentration is necessary. No satisfactory control of the carbohydrate metabolism is possible with oral antidiabetic agents in pregnant women.
For that reason GLURENORM should not be used in pregnant or lactating women. Should a patient become pregnant or intend to become pregnant during treatment, GLURENORM should be discontinued and treatment should be switched to insulin.
Clinical and non-clinical studies on the influence of GLURENORM on fertility are not available
